Finanzas de Nutriband Inc (NTRB)NTRBNutriband Inc

Nutriband Inc (NTRB) generates its revenue primarily from Sale of goods, which accounts for 100.0% of total sales, equivalent to $400.71K. Understanding this concentration is critical for investors evaluating how NTRB navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Nutriband Inc maintains a gross margin of 41.57%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -203.57%, while the net margin is -201.26%. These profitability ratios, combined with a Return on Equity (ROE) of -100.79%, provide a clear picture of how effectively NTRB converts its operational activities into shareholder value.

In the context of the broader market, NTRB competes directly with industry leaders such as HYPR and OM. With a market capitalization of $67.79M, it holds a significant position in the sector. When comparing efficiency, NTRB's gross margin of 41.57% stands against HYPR's 50.72% and OM's 40.69%. Such benchmarking helps identify whether Nutriband Inc is trading at a premium or discount relative to its financial performance.

Nutriband's revenue has shown fluctuations, with the latest quarter (Q3 2026) reporting $346,058, and a gross margin that has decreased to 19.80%. The company has reported significant net income losses, with the latest being -$3,872,367 in Q3 2026.